Immunogenic anti-cancer chemotherapy as an emerging concept
- 23 June 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 20 (5) , 545-557
- https://doi.org/10.1016/j.coi.2008.05.008
Abstract
No abstract availableThis publication has 98 references indexed in Scilit:
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyPublished by Elsevier ,2008
- Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse modelProceedings of the National Academy of Sciences, 2008
- Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillanceProceedings of the National Academy of Sciences, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Molecular characteristics of immunogenic cancer cell deathCell Death & Differentiation, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- Identification of a factor that links apoptotic cells to phagocytesNature, 2002